Seqker Biosciences, Inc.

This study tests a personalized vaccine made from your tumor's unique mutations. It aims to train your immune system to attack cancer cells. The trial includes 10 adults with advanced or high-risk solid tumors. Participants receive the vaccine plus immune-boosting drugs over seve…